Meningitis: Vaccination
(asked on 2nd February 2015) - View Source
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, what steps he is taking to ensure progress on price negotiations with Novartis for the Meningitis B vaccine.
This question was answered on 5th February 2015
We are seeking to reach a positive conclusion to the negotiations with Novartis for supply of the meningococcal B (MenB) vaccine, Bexsero® at a cost-effective price, as recommended by the Joint Committee on Vaccination and Immunisation as soon as possible. The introduction of an NHS MenB immunisation programme for infants will depend on the outcome of these negotiations.